Searched for
ICLINIC HEALTHCARE
Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...- Amazon developing breast & skin cancer vaccines; e-tail giant gears up for Phase 1 trialsThe e-tail giant has partnered with the US-based Fred Hutchinson Cancer Center.
- European shares slip as inflation debate keeps bears on prowlThe pan-European STOXX 600 was down 0.1 per cent by 0748 GMT, with the technology and healthcare indexes falling more than 0.5 per cent.
- Yashoda Hospitals joins Natco for clinical trials of Molnupiravir for Covid patientsPre-clinical (animal) studies have found that Molnupiravir has remarkably reduced SARS-CoV-2 load and was found to have completely suppress...
- Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19 vaccineThe Phase-II study of the vaccine, ZyCoV-D, had been conducted in over 1,000 healthy adult volunteers as part of the adaptive Phase-I and I...
- Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical...
- PM's presence to motivate company in quest to bridge unmet healthcare needs: Zydus CadilaThe Zydus family comprising 25,000 Zydans stands committed to the 'Aatmanirbhar Bharat' mission and offering the nation safe and efficaciou...
- 'Excellent safety' of 2 indigenous COVID candidate vaccines revealed during Phase-I trials: MinisterSerum Institute of India (SII) and ICMR have partnered for clinical development of two global vaccine candidates.
- Zydus Cadila to commence phase II clinical trials of COVID-19 vaccine ZyCoV-D from Aug 6"The company reports that the doses of the vaccine administered to healthy volunteers in the phase I clinical trial, which began on July 15...
- Cadila Healthcare Ltd may soon start human trials of vaccineAt a recent meeting at the Central Drugs Standard Control Organisation (CDSCO)-the regulatory authority of India, subject experts recommend...
- Market Movers: Voda gains 6%, metals, pharma names rally; 66 stocks ‘oversold’Sensex gained 479 points to 38,623 while Nifty added 170 points to close at 11,303.
- Ravi Jaipuria's RJ Corp buys health startup iClinic; Diagno to be merged with itiClinic, which has a clutch of investors besides Mukerji and Berry, was set up in 2012 with the business model of offering healthcare to pe...
- Healthcare startups tying up funds to increase footprintTechnology-enabled models, like iClinic & iKure, are emerging in India which are addressing lack of healthcare facilities in underserved re...
- How Varun Berry is changing the way Britannia functionsBerry has been tightening left, right and centre. He’s been nudging sales managers to step out of office and engage more with trade partner...
- Executives quitting cushy jobs at big firms in exchange for challenging assignments in startups“Unlike MNCs which have pre-defined roles, the challenges, the sense of ownership and the work culture in a start-up is more fulfilling."
- ET Profile: Varun Berry loving new challenge as Britannia's head of India operationsBerry has flung himself at this job with characteristic gusto. "I am a dreamer," he says. "When I fail, at times, to achieve those dreams, ...
- Queppelin's right ‘App’titude for enterprisesQueppelin is attempting to be the mobile application partner and consultant to enterprises large and small.
- Piramal completes Phase-I trials of new cancer moleculePiramal Healthcare today said it has completed the first phase of clinical trials of a new oral drug for treating cancer and will move to t...
- Piramal Life may unveil new chemical entity by 2011Piramal Life Sciences, the listed research and development (R&D) subsidiary of Piramal Healthcare, is hoping to hit the market with its fir...
- 'Clinical research norms restrictive'Onkar Kanwar, the chairman of 260-bed multi-specialty Gurgaon hospital of Artemis Health Sciences, shares the company's plans with ET.
Load More
